Abstract Acute exacerbation of ILD (AE-ILD) is a common reason for hospitalization; it is also associated with significant mortality. Less is known about the prognostic significance of other events causing acute, non-elective hospitalizations in ILD patients. ILD patients hospitalized due to acute respiratory worsening were collected from medical records. Reasons for respiratory deterioration were classified into AE-ILDs and other causes. Clinical features and survival data of idiopathic pulmonary fibrosis (IPF) and other types of ILDs were evaluated and compared. In all, 237 patients (138 with IPF and 99 with other ILD) fulfilled the inclusion criteria. Of the non-IPF ILD types, the most prevalent subgroups were connective tissue disease-...
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic disease limited to the lun...
Interstitial lung diseases (ILDs) are a heterogeneous group of diseases characterized by widespread ...
The aim of this study was to determine the prevalence, characteristics and outcomes of patients with...
Interstitial lung diseases (ILDs) comprise a wide group of pulmonary parenchymal disorders. These pa...
Abstract Background: The aim of this study was to compare the clinical characteristics, causes of d...
Interstitial lung diseases (ILDs) comprise a wide group of pulmonary parenchymal disorders. These pa...
BackgroundInterstitial lung diseases (ILDs) are disorders of the lung parenchyma. The pathogenesis, ...
Data on interstitial lung disease (ILD) outcomes in the intensive care unit (ICU) is of limited valu...
Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) has been defined as an acute, clinicall...
Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease characterized by progressive loss of ...
Background: Patients with chronic known or unknown interstitial lung disease (ILD) may present with ...
Acute exacerbation (AE) is a possible manifestation of interstitial lung diseases (ILD) associated t...
Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic dis...
Abstract Fibrosing interstitial lung diseases (ILD) are a group of diseases in which healthy periph...
<div><p>Background</p><p>Patients with chronic known or unknown interstitial lung disease (ILD) may ...
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic disease limited to the lun...
Interstitial lung diseases (ILDs) are a heterogeneous group of diseases characterized by widespread ...
The aim of this study was to determine the prevalence, characteristics and outcomes of patients with...
Interstitial lung diseases (ILDs) comprise a wide group of pulmonary parenchymal disorders. These pa...
Abstract Background: The aim of this study was to compare the clinical characteristics, causes of d...
Interstitial lung diseases (ILDs) comprise a wide group of pulmonary parenchymal disorders. These pa...
BackgroundInterstitial lung diseases (ILDs) are disorders of the lung parenchyma. The pathogenesis, ...
Data on interstitial lung disease (ILD) outcomes in the intensive care unit (ICU) is of limited valu...
Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) has been defined as an acute, clinicall...
Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease characterized by progressive loss of ...
Background: Patients with chronic known or unknown interstitial lung disease (ILD) may present with ...
Acute exacerbation (AE) is a possible manifestation of interstitial lung diseases (ILD) associated t...
Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic dis...
Abstract Fibrosing interstitial lung diseases (ILD) are a group of diseases in which healthy periph...
<div><p>Background</p><p>Patients with chronic known or unknown interstitial lung disease (ILD) may ...
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic disease limited to the lun...
Interstitial lung diseases (ILDs) are a heterogeneous group of diseases characterized by widespread ...
The aim of this study was to determine the prevalence, characteristics and outcomes of patients with...